banner
HIF inhibitor Vadadustat, Purity ≥98%

Cat. No.: X24-06-ZQ532

HIF inhibitor Vadadustat, Purity ≥98%

Synonym: 1000025-07-9; HIF inhibitor; AKB-6548; AKB 6548; AKB6548; PG-1016548; PG 1016548; PG1016548; B-506; B506

  • CAS Number: 1000025-07-9
  • Compound CID: 23634441
Product Size
2 mg; 5 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Vadadustat, soluble in DMSO and ethanol and insoluble in water, is designed to disrupt the hypoxia-inducible factor (HIF) pathway, aiming to hinder cancer cell survival and adaptation in low-oxygen environments characteristic of tumor growth.
Molecular Weight
306.7
Molecular Formula
C14H11ClN2O4
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 59 mg/mL (192.37 mM); Water: Insoluble; Ethanol: 9 mg/mL (29.34 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Vadadustat is employed in investigating treatments for anemia by modulating HIF pathways to stimulate erythropoiesis.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0